Drug Manufacturers During the model pre-implementation period in early 2026, CMS negotiated with Novo Nordisk and Eli Lilly to come to agreement on the key parameters of the model, including details about pricing of the model drugs, cost sharing, rebate calculations, access policies (i.e., coverage criteria and prior authorization policies), the length of the agreement, data sharing arrangements, and agreement on lifestyle supports that will be offered
According to health industry pollster KFF, in 2025 1 in 8 people 12% said they were currently taking a GLP-1 drug, and 18% said they have taken the weight-loss drug at some point
Combining injections allows your provider to create a comprehensive wellness plan tailored to your goals
McLennan SV, Min D, Yue DK
TRP14: thioredoxin-related protein of 14 kDa
This industry is transforming rapidly, influenced by innovations such as artificial intelligence and personalized medicine, which promise to reshape the way new drugs are developed and brought to market